Richard Saintvilus

Richard Saintvilus

InvestorPlace Contributor

After 20 successful years in the IT industry, Richard Saintvilus decided his second act would be as a stock analyst. Saintvilus founded WallStPlaybook.com to help educate investors about the highs and lows of the stock market and ways to grow and preserve their wealth. His work has been featured on CNBC, Yahoo! Finance, USA Today, MSN Money, Forbes, and numerous other outlets. You can follow him on Twitter at @Richard_Stv.

Recent Articles

Why Chesapeake Energy Corporation (CHK) Stock Is Still a Massive Risk

By Richard Saintvilus, InvestorPlace Contributor

There are too many "if" scenarios to rely on Chesapeake Energy stock. For now, investors ought to avoid CHK.

Buy Exxon Mobil Corporation (XOM) Stock Ahead of Earnings

By Richard Saintvilus, InvestorPlace Contributor

Exxon (XOM) will release earnings on Friday, and analysts expect impressive year-over-year gains that could push XOM stock over $100/share.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Still Looks Toxic

By Richard Saintvilus, InvestorPlace Contributor

Valeant Pharmaceuticals (VRX) is desperate for cash and the price of new psoriasis drug shows the despair at VRX stock.

Intel Corporation (INTC) Stock Is a No-Brainer Buy Ahead of Earnings

By Richard Saintvilus, InvestorPlace Contributor

INTC stock has been listless so far in 2017, but look for Intel to see a surge in the next few months with a goal of around $45.

Schlumberger Limited (SLB) Stock Is Damaged Goods … For Now

By Richard Saintvilus, InvestorPlace Contributor

SLB stock should be avoided for now. You should only consider Shlumberger once oil prices are above $50 and the industry improves.

Buy Boeing Co (BA) Stock on This Post-Earnings Dip

By Richard Saintvilus, InvestorPlace Contributor

Wall Street is giving Boeing (BA) the cold shoulder Wednesday despite a Q1 beat. That's too bad, because BA stock can still pay off.

Rite Aid Corporation (RAD) Stock Is a Better Buy After Q4 Earnings

By Richard Saintvilus, InvestorPlace Contributor

Rite Aid (RAD) pulled off top- and bottom-line beats for fiscal Q4, showing that the drug store chain is performing better than RAD stock.

T-Mobile US Inc (TMUS) Stock Still Buy-Worthy After Big Q1 Beat

By Richard Saintvilus, InvestorPlace Contributor

T-Mobile (TMUS) just crushed its Q1 earnings estimates. Right now, parting with TMUS stock seems riskier than holding at current highs.

Why Sprint Corp (S) Stock Could Rise More Than 20% in a Year

By Richard Saintvilus, InvestorPlace Contributor

There are tons of growth catalysts that can send S stock towards 17% to 23% returns in the next 12 to 18 months. Here's what you need to know about Sprint.

Why Amazon.com, Inc. (AMZN) Stock Will Soar to $1,100

By Richard Saintvilus, InvestorPlace Contributor

Amazon's unconventional methods have helped investors rich over the last five years. Here's what you need to know about AMZN stock.

Load More